Lumira Capital closes $10 mln commitment from VCAP
Canadian life sciences venture capital firm Lumira Capital has closed the $10 million capital commitment made to its latest partnership, Lumira Capital II, by the federal Venture Capital Action Plan (VCAP). In September, the $400 million VCAP awarded $50 million to four "high performing" Canadian funds, including the Lumira fund. The Toronto-based Lumira, which invests in North American companies in biotherapeutics, medical technology and health and wellness sectors, is also backed by Business Development Bank of Canada, Teralys Capital, Fonds de solidarité FTQ, Northleaf Capital Partners, Fondaction CSN and Merck & Co.
12 November 2013•4 mins read
